Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.88M Buy
300,400
+107,500
+56% +$1.92M ﹤0.01% 2110
2026
Q1
$3.67M Buy
192,900
+63,900
+50% +$1.23M ﹤0.01% 2054
2025
Q4
$2.11M Sell
129,000
-141,000
-52% -$2.48M ﹤0.01% 2368
2025
Q3
$5.07M Buy
270,000
+57,600
+27% +$1.03M ﹤0.01% 1553
2025
Q2
$4.29M Buy
212,400
+19,200
+10% +$332K ﹤0.01% 1490
2025
Q1
$2.66M Buy
193,200
+81,300
+73% +$1.12M ﹤0.01% 1620
2024
Q4
$1.33M Buy
111,900
+20,300
+22% +$320K ﹤0.01% 2168
2024
Q3
$1.64M Buy
91,600
+53,000
+137% +$966K ﹤0.01% 1785
2024
Q2
$679K Buy
38,600
+20,300
+111% +$419K ﹤0.01% 2172
2024
Q1
$470K Sell
18,300
-87,100
-83% -$2.18M ﹤0.01% 2069
2023
Q4
$2.75M Buy
105,400
+62,400
+145% +$1.42M ﹤0.01% 1094
2023
Q3
$991K Buy
+43,000
New +$1.08M ﹤0.01% 1232

Other funds holding XP

IMC Chicago's XP Position: Q2 2026 in Review

IMC Chicago increased its XP (XP) stake by 6.6% in Q2 2026, buying an estimated $21.7K and bringing the position to 19,621 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #5160.

IMC Chicago first reported a position in XP in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.18M in Q4 2025. 321 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • IMC Chicago held 19,621 shares of XP worth $319K as of Q2 2026.
  • IMC Chicago bought 1,215 XP shares in Q2 2026, an estimated $21.7K.
  • XP made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5160 holding.
  • IMC Chicago first reported a position in XP in Q4 2024 and has held it in 6 quarters since.
  • IMC Chicago's XP position peaked at $2.18M in Q4 2025.
  • 321 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.